| James William Jordan, MD | |
|
1321 Colby Ave Fl 3, Everett, WA 98201-1665 | |
| (425) 261-2000 | |
| (425) 261-4078 |
| Full Name | James William Jordan |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 20 Years |
| Location | 1321 Colby Ave Fl 3, Everett, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417156993 | NPI | - | NPPES |
| 2015739 | Medicaid | WA | |
| 2801463 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 57.008958 (Ohio) | Secondary |
| 2084N0400X | Psychiatry & Neurology - Neurology | MD60251434 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence Regional Medical Center Everett | Everett, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services - Washington | 2860552973 | 217 |
| Providence Health And Services Mt | 6608786306 | 272 |
| Providence Health And Services Oregon | 0648183608 | 1328 |
| Providence Health And Services Washington | 0345139929 | 687 |
| Providence Health And Services Washington | 6709782600 | 393 |
| Providence Health And Services- Washington | 1557408176 | 143 |
| Providence Health And Services- Washington | 8325100480 | 420 |
| Providence Medical Institute | 5991609737 | 290 |
| Swedish Health Services | 0244138196 | 834 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174744304 PECOS PAC ID: 6709782600 Enrollment ID: O20031211000028 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | The Everett Clinic Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831186766 PECOS PAC ID: 6406752153 Enrollment ID: O20031211000922 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | Swedish Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689612954 PECOS PAC ID: 0244138196 Enrollment ID: O20031230000187 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194099390 PECOS PAC ID: 0345139929 Enrollment ID: O20040311001453 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | Providence Health & Services Oregon |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104097906 PECOS PAC ID: 0648183608 Enrollment ID: O20080630000201 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | Providence Health & Services - Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922259738 PECOS PAC ID: 2860552973 Enrollment ID: O20081223000478 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124270715 PECOS PAC ID: 8325100480 Enrollment ID: O20081224000111 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | Providence Health & Services-wa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336390442 PECOS PAC ID: 0648330787 Enrollment ID: O20090106000737 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | Providence Medical Institute |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760425862 PECOS PAC ID: 5991609737 Enrollment ID: O20190109001974 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093956278 PECOS PAC ID: 1557408176 Enrollment ID: O20190123001516 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Entity Name | Providence Health & Services Mt |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215222617 PECOS PAC ID: 6608786306 Enrollment ID: O20190128001139 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James William Jordan, MD Po Box 5127, Everett, WA 98206-5127 Ph: () - | James William Jordan, MD 1321 Colby Ave Fl 3, Everett, WA 98201-1665 Ph: (425) 261-2000 |
News Archive
Considerable evidence has accumulated to suggest that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus may spread through prolonged or brief contact with infected patients - with the infection being spread through respiratory droplets and aerosols. The need to understand how these infectious droplets behave becomes ever more urgent. A recent study published in the preprint server medRxiv* in October 2020 reports the results of such an investigation.
E-18 Corp. (OTCBB: ETEN), through its wholly owned subsidiary, SquareOne Medical, Inc., doing business as Protectus Medical Devices ("Protectus Medical Devices"), today announces completion of the US patent filing for the Protectus Safety Dental Syringe, broadening the company's market opportunities to include the multi-billion dollar dental syringe market.
Children with frequent infections in the first 18 months of life have a slightly increased risk of later developing coeliac disease compared with children who have few infections. This is the conclusion from a study by the Norwegian Institute of Public Health.
H. Julia Hannay, the John and Rebecca Moores Professor of Psychology at the University of Houston (UH), received the Lifetime Distinguished Career Award from the International Neuropsychological Society (INS) at its 41st annual meeting in Waikoloa, Hawaii. The award recognizes her contributions to the field of neuropsychology.
Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal 510(k) clearance to market its Amicus® blood cell separator for collecting human platelets stored in InterSol® platelet additive solution (PAS 3). Fenwal's InterSol® solution was approved by the FDA in December 2009 under a new drug application. It is the first and only platelet additive solution now available in America.
› Verified 8 days ago
Dr. Vikram Manjunath Gopal, D.O. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12800 Bothell Everett Hwy, Everett, WA 98208 Phone: 425-316-5062 | |
Dr. Zsolt A Lorant, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1728 W Marine View Dr, Everett, WA 98201 Phone: 425-339-5453 Fax: 425-252-4441 | |
Derek Chen Huang, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-339-5408 | |
Dr. Shirin Khan Schilling, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 12728 19th Ave Se Ste 300, Everett, WA 98208 Phone: 425-252-1116 | |
Nicola Carlisle, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3901 Hoyt Ave, Everett, WA 98201 Phone: 425-339-5408 Fax: 425-303-3096 | |
Dr. Tasca D Snow, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 4526 Federal Ave, Everett, WA 98203 Phone: 425-349-6200 Fax: 425-349-6887 | |
Robert Nadol, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1728 W Marine View Dr Ste 106, Everett, WA 98201 Phone: 425-339-5453 Fax: 425-252-4441 |